Log in

Kodiak Sciences News Headlines (NYSE:KOD)

$63.45
+0.56 (+0.89 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$60.75
Now: $63.45
$64.50
50-Day Range
$19.98
MA: $33.76
$74.21
52-Week Range
$5.65
Now: $63.45
$74.50
Volume387,872 shs
Average Volume250,313 shs
Market Capitalization$2.35 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Kodiak Sciences (NYSE KOD) News Headlines

Source:
DateHeadline
Bros. Advisors Lp Baker Purchases 1,902,173 Shares of Kodiak Sciences Inc. (NYSE:KOD) StockBros. Advisors Lp Baker Purchases 1,902,173 Shares of Kodiak Sciences Inc. (NYSE:KOD) Stock
www.americanbankingnews.com - December 6 at 8:26 PM
Kodiak Sciences Announces Closing of $317.4 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesKodiak Sciences Announces Closing of $317.4 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - December 6 at 5:37 PM
Why Chesapeake Energy, PG&E, and Kodiak Sciences Jumped TodayWhy Chesapeake Energy, PG&E, and Kodiak Sciences Jumped Today
www.fool.com - December 4 at 5:17 PM
Why Kodiak Sciences Stock Is Jumping TodayWhy Kodiak Sciences Stock Is Jumping Today
www.fool.com - December 4 at 12:16 PM
Kodiak Sciences prices $276M equity offeringKodiak Sciences prices $276M equity offering
seekingalpha.com - December 4 at 7:15 AM
Thinking about buying stock in E*TRADE, Kodiak Sciences, Micron Technology, Nio, or Wells Fargo?Thinking about buying stock in E*TRADE, Kodiak Sciences, Micron Technology, Nio, or Wells Fargo?
www.marketwatch.com - December 3 at 10:09 AM
Kodiak Sciences down 9% after hours on equity offeringKodiak Sciences down 9% after hours on equity offering
seekingalpha.com - December 2 at 10:23 PM
BRIEF-Kodiak Sciences Sells Future Royalties On KSI-301 For $225 Mln To Baker Bros. AdvisorsBRIEF-Kodiak Sciences Sells Future Royalties On KSI-301 For $225 Mln To Baker Bros. Advisors
www.msn.com - December 2 at 10:23 PM
Why AK Steel, Kodiak Sciences, and Sorrento Therapeutics Jumped TodayWhy AK Steel, Kodiak Sciences, and Sorrento Therapeutics Jumped Today
www.fool.com - December 2 at 5:23 PM
Kodiak Sciences Announces Proposed Offering of Common StockKodiak Sciences Announces Proposed Offering of Common Stock
finance.yahoo.com - December 2 at 5:23 PM
Why Kodiak Sciences Stock Is Skyrocketing TodayWhy Kodiak Sciences Stock Is Skyrocketing Today
www.fool.com - December 2 at 12:22 PM
Kodiak Sciences (NYSE:KOD) Receives "Buy" Rating from Chardan CapitalKodiak Sciences (NYSE:KOD) Receives "Buy" Rating from Chardan Capital
www.americanbankingnews.com - December 2 at 11:32 AM
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. AdvisorsKodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
finance.yahoo.com - December 2 at 7:22 AM
Kodiak Sciences to Present at the Evercore ISI HealthCONx ConferenceKodiak Sciences to Present at the Evercore ISI HealthCONx Conference
finance.yahoo.com - December 2 at 7:22 AM
Brokerages Anticipate Kodiak Sciences Inc. (NYSE:KOD) to Post ($0.46) EPSBrokerages Anticipate Kodiak Sciences Inc. (NYSE:KOD) to Post ($0.46) EPS
www.americanbankingnews.com - November 30 at 4:16 PM
Zacks: Brokerages Expect Kodiak Sciences Inc. (NYSE:KOD) Will Announce Earnings of -$0.46 Per ShareZacks: Brokerages Expect Kodiak Sciences Inc. (NYSE:KOD) Will Announce Earnings of -$0.46 Per Share
www.americanbankingnews.com - November 22 at 9:15 PM
Kodiak Sciences Inc. (KOD) Q3 2019 Earnings Call TranscriptKodiak Sciences Inc. (KOD) Q3 2019 Earnings Call Transcript
www.fool.com - November 13 at 4:13 AM
BRIEF-Kodiak Sciences Reports Q3 Loss Per Share $0.33BRIEF-Kodiak Sciences Reports Q3 Loss Per Share $0.33
www.msn.com - November 12 at 10:14 PM
Kodiak Sciences Announces Third Quarter 2019 Financial Results and Recent Business HighlightsKodiak Sciences Announces Third Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - November 12 at 7:13 AM
Kodiak Sciences Announces Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Academy of Ophthalmology Annual Meeting Retina Subspecialty DayKodiak Sciences Announces Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Academy of Ophthalmology Annual Meeting Retina Subspecialty Day
finance.yahoo.com - October 24 at 1:45 PM
Kodiak Sciences Announces Safety, Efficacy and...Kodiak Sciences Announces Safety, Efficacy and...
www.benzinga.com - October 11 at 10:43 PM
Kodiak Sciences to Host R&D Day on October 14 in San Francisco to Highlight Recent Clinical Progress and Development Planning for KSI-301Kodiak Sciences to Host R&D Day on October 14 in San Francisco to Highlight Recent Clinical Progress and Development Planning for KSI-301
www.prnewswire.com - October 11 at 6:27 AM
Kodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for wet AMD at The Retina Society Annual MeetingKodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for wet AMD at The Retina Society Annual Meeting
finance.yahoo.com - September 26 at 5:40 PM
Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual MeetingKodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting
finance.yahoo.com - September 26 at 5:40 PM
Kodiak Sciences Inc. (NASDAQ:KOD) Insiders Increased Their HoldingsKodiak Sciences Inc. (NASDAQ:KOD) Insiders Increased Their Holdings
finance.yahoo.com - August 23 at 12:26 PM
Kodiak Sciences EPS misses by $0.02Kodiak Sciences EPS misses by $0.02
seekingalpha.com - August 14 at 11:15 AM
Kodiak Sciences to Present at Wedbush PacGrow Healthcare ConferenceKodiak Sciences to Present at Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 8 at 9:00 AM
Kodiak Sciences Says Eye Disease Treatment Boosted Vision,RetinaKodiak Sciences Says Eye Disease Treatment Boosted Vision,Retina
www.bloomberg.com - July 27 at 3:37 PM
Kodiak Sciences Announces Upcoming Presentation at American Society of Retina Specialists (ASRS) 2019 Annual MeetingKodiak Sciences Announces Upcoming Presentation at American Society of Retina Specialists (ASRS) 2019 Annual Meeting
finance.yahoo.com - July 24 at 9:12 AM
Kodiak Sciences Shares March Higher, Can It Continue?Kodiak Sciences' Shares March Higher, Can It Continue?
www.nasdaq.com - July 17 at 12:02 PM
Kodiak Sciences' Shares March Higher, Can It Continue?Kodiak Sciences' Shares March Higher, Can It Continue?
finance.yahoo.com - July 17 at 12:02 PM
Kodiak Catches Investors Eye Kodiak Catches Investors' Eye
www.rttnews.com - July 15 at 3:31 AM
How Much Of Kodiak Sciences Inc. (NASDAQ:KOD) Do Insiders Own?How Much Of Kodiak Sciences Inc. (NASDAQ:KOD) Do Insiders Own?
finance.yahoo.com - May 25 at 11:30 AM
Kodiak Sciences Inc. (KOD) Shares March Higher, Can It Continue?Kodiak Sciences Inc. (KOD) Shares March Higher, Can It Continue?
finance.yahoo.com - May 24 at 12:02 PM
Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference 2019Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference 2019
www.prnewswire.com - May 9 at 12:13 PM
Kodiak Sciences Announces Presentations at ARVO 2019 Annual MeetingKodiak Sciences Announces Presentations at ARVO 2019 Annual Meeting
finance.yahoo.com - April 26 at 11:54 AM
Kodiak Sciences Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Business HighlightsKodiak Sciences Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights
finance.yahoo.com - March 28 at 11:26 AM
Kodiak Sciences Inc Estimate MomentumKodiak Sciences Inc Estimate Momentum
www.nasdaq.com - March 20 at 8:39 PM
Kodiak Sciences to Present at the Barclays Global Healthcare ConferenceKodiak Sciences to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 7 at 10:23 AM
The Zacks Analyst Blog Highlights: Microsoft, Kodiak Sciences, General Motors and Procter & GambleThe Zacks Analyst Blog Highlights: Microsoft, Kodiak Sciences, General Motors and Procter & Gamble
finance.yahoo.com - March 1 at 3:32 PM
Wall Street Takes Notice of These 4 Stocks - Should You?Wall Street Takes Notice of These 4 Stocks - Should You?
finance.yahoo.com - February 28 at 10:02 AM
Kodiak Sciences Announces Upcoming Presentation of KSI-301 12-Week Phase 1a Study Data at Angiogenesis, Exudation, and Degeneration 2019 MeetingKodiak Sciences Announces Upcoming Presentation of KSI-301 12-Week Phase 1a Study Data at Angiogenesis, Exudation, and Degeneration 2019 Meeting
finance.yahoo.com - February 21 at 10:19 AM
Chardan likes Kodiak Sciences in premarket analyst actionChardan likes Kodiak Sciences in premarket analyst action
seekingalpha.com - February 20 at 10:01 AM
Have Insiders Been Buying Kodiak Sciences Inc. (NASDAQ:KOD) Shares?Have Insiders Been Buying Kodiak Sciences Inc. (NASDAQ:KOD) Shares?
finance.yahoo.com - January 18 at 3:30 PM
Kodiak Sciences Inc.Kodiak Sciences Inc.
www.barrons.com - January 9 at 9:15 AM
Kodiak Sciences Added to Russell 2000®, 3000® and Microcap® IndexesKodiak Sciences Added to Russell 2000®, 3000® and Microcap® Indexes
finance.yahoo.com - December 24 at 3:21 PM
Kodiak Sciences completes 12-week phase 1a study of KSI-301 in patients with diabetic macular edemaKodiak Sciences completes 12-week phase 1a study of KSI-301 in patients with diabetic macular edema
seekingalpha.com - December 21 at 7:38 AM
Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with Diabetic Macular Edema Demonstrating Safety and Durability of Responses Following Single Dose of Intravitreal Anti-VEGF Antibody Biopolymer ConjugateKodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with Diabetic Macular Edema Demonstrating Safety and Durability of Responses Following Single Dose of Intravitreal Anti-VEGF Antibody Biopolymer Conjugate
finance.yahoo.com - December 21 at 7:38 AM
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Featured Article: What is Blockchain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel